FDA
-
-
-
-
-
-
-
TLC (TLC) Granted Australian & Taiwan Approval to Begin Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
-
-
-
-
-
-
-
TLC Announces Initiation of Phase III Pivotal Clinical Trial of TLC599 for the Treatment of Osteoarthritis Knee Pain
-
-
-
-
-
-
-
EMA Grants Orphan Drug Designation to TLC178 for the Treatment of Soft Tissue Sarcoma
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

